The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2
Sarah Line Skovbakke(University of Copenhagen), Cláes Dahlgren(University of Gothenburg), Huamei Forsman(Harvard University), Henrik Franzyk(University of Copenhagen), Camilla Josephine Larsen, Peter M. H. Heegaard(Technical University of Denmark)
Cited by 22
Related Papers
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
|The Journal of Immunology|1995|314
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes
|Infection and Immunity|1983|244